| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Biochemical Pharmacology, Laboratory of Viral Oncology, and Pathologic Anatomy Branch, National Cancer Institute, Bethesda, Maryland)
Eight drugs were tested against the Rauscher virus-induced leukemia. In virus-inoculated mice a limited course of drug therapy was initiated after the mice had become leukemic. Netropsin, Melphalan, 6-mercaptopurine, and 5-fluorouracil produced a twofold increase in the survival time of leukemic animals. Cytoxan and Vincristine were moderately effective; p-anisaldehyde thiosemicarbazone and methylglyoxalbis-guanylhydrazone were only minimally effective. Inhibition of splenomegaly was observed in animals subjected to effective therapy.
* Present address, Department of Pathology, Georgetown University Medical School, Washington, D.C.
Received 5/15/63.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |